The global N-acetylcysteine market size anticipated to expand at an unwavering rate on account of the rising prevalence of chronic obstructive pulmonary disease (COPD) worldwide, highlights Fortune Business Insights™ in its report, the title” N-Acetylcysteine Market, 2022-2029”.

COPD is a type of lung disease characterized by a steady reduction in airflow and worsening breathlessness in the patient. Though manageable, it can turn life-threatening if it is not treated in time. More importantly, the incidence of COPD is increasing around the globe. According to the World Health Organization (WHO), COPD affected approximately 251 million people worldwide in 2016 and claimed roughly 3.7 million lives. Thus, the need for effective therapies and medications for COPD is heightening globally. N-Acetylcysteine, or NAC, is an essential Active Pharmaceutical Ingredient (API) for developing treatments for COPD. This substance facilitates the removal of pulmonary secretions and clears the airway, thus preventing bacteria-stimulated mucus hyper-secretion in COPD patients.

Get Sample PDF Brochure:-           

www.fortunebusinessinsights.com/enquiry/request-sample-pdf/n-acetylcysteine-market-103964

Segments-

Based on product type, the market has been segregated into sprays, tracheal drips, and tablets. Based on application, it is segmented into medicines, nutrition supplements, and others. Region-wise, the market has been categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Report Highlights-

The report incorporates tangible insights into the trends, drivers, and various other aspects of the market, as well as supplies actionable analysis of the factors restricting the growth of the market. Further, it contains a granular study of the different market segments and provides a detailed evaluation of the regional prospects and the competitive dynamics influencing the market.

Drivers & Restraints-

Digitization in the Chemical Industry to Spawn New Opportunities

The market for N-Acetylcysteine is being driven by digitization, which is an evolving trend in the chemical industry. Companies are capturing and analyzing critical and applicable data and deriving valuable insights using digital tools, allowing them to make better-informed and higher-quality decisions. Machine learning (ML) and artificial intelligence (AI) are examples of advanced technologies. For instance, ML is being leveraged by chemical companies to design drugs and predict toxicity in ingredients and substances. The expansion of this market is being aided by rising urbanization and globalization, especially in emerging economies. This is an exciting growth driver for this market as lung disorders such as COPD and asthma are commonly seen to be afflicting working populations residing in urban spaces. Therefore, as urban areas continue to grow, the adoption of NAC for engineering medicines is likely to increase in the forthcoming years.

Ask for Customization:

www.fortunebusinessinsights.com/enquiry/customization/n-acetylcysteine-market-103964

Regional Insights-

Heavy Investments in Healthcare to Stimulate the North America Market

Supported by huge investments in healthcare and medical R&D, North America is projected to lead the N-acetylcysteine market share. In addition, the robust healthcare infrastructure in the US and Canada will also aid the progress of the market in the region. The regional market is also surging due to the increased research in developing medications to cure HIV.

Due to China’s broad manufacturing base, the market in Asia Pacific is expected to expand significantly. On the other hand, the use of N-acetylcysteine for preventing paracetamol poisoning is expected to drive market growth in Europe.

Competitive Landscape-

Presence of Small and Large Players to Bolster Market Prospects

The key raw material for acetylcysteine is L-cysteine, which is widely available. The acetylcysteine manufacturing process is also well-developed. As a result, there are several acetylcysteine manufacturers around the world. Zambon, Moehs, Pharmazell, Nippon Rika, Chengyi Pharma, Wuhan Grand Hoyo, and Manus Aktteva Biopharma are significant global producers of N-acetylcysteine in the world. This sector has a high level of market concentration.

Industry Development-

July 2019: Zambon completed its transformational acquisition of Breath Therapeutics for rare respiratory diseases such as Bronchiolitis Syndrome.

List of Key Players Profiled in the N-Acetylcysteine Market Report

  • Zambon
  • Pharmazell
  • Manus Aktteva Biopharma
  • Wuxi Enovo Chemical
  • Xinyi Hanling Biological Engineering
  • Nippon Rika
  • Moehs

Read Related News:             

Wood Flooring Market Latest Industry Size, Growth, Share, Demand, Trends, Competitive Landscape and Forecasts to 2029

Wood Flooring Market Size, Outlook, Geographical Segmentation, Business Challenges and Opportunities till 2029

Wood Flooring Market Size, Gross Margin, Trends, Future Demand, Analysis by Top Leading Players and Forecast till 2029

Wood Flooring Market Key Drivers, Restraints, Industry Size & Share, Opportunities, Trends, and Forecasts up to 2029

Wood Flooring Market Data Current and Future Trends, Industry Size, Share, Revenue, Business Growth Forecast to 2029

Wood Flooring Market Latest Industry Size, Growth, Share, Demand, Trends, Competitive Landscape and Forecasts to 2029

Wood Flooring Market Size, Outlook, Geographical Segmentation, Business Challenges and Opportunities till 2029

 

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Address:

Fortune Business Insights Pvt. Ltd.9th Floor, Icon Tower, Baner –

Mahalunge Road, Baner, Pune-411045,

Maharashtra, India.

Phone:

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: [email protected]

LinkedIn Facebook Twitter